DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Meniere’s Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Meniere’s Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline...
March 2021
60 pages
Ocular Hypertension - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Ocular Hypertension - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipelin...
March 2021
60 pages
Primary Open Angle Glaucoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Primary Open Angle Glaucoma – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+...
March 2021
60 pages
Renal Cell Carcinoma - Pipeline Insight, 202
US$ 3,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Renal Cell Carcinoma – Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pipeli...
March 2021
120 pages
CAR-T - Pipeline Insight, 2021
US$ 3,000.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “CAR-T – Pipeline Insight, 2021,” report provides comprehensive insights about 300+ companies and 300+ pipeline drugs in C...
March 2021
360 pages
Acute Liver Failure - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Acute Liver Failure – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline...
March 2021
60 pages
Anal Cancer - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Anal Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in...
March 2021
60 pages
Hepatorenal syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Hepatorenal syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
March 2021
60 pages
Intraocular (Uveal) melanoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Intraocular (Uveal) melanoma – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15...
March 2021
120 pages
Waldenstrom’s macroglobulinaemia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Waldenstrom’s macroglobulinaemia – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies an...
March 2021
120 pages
Acute optic neuritis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Acute optic neuritis - Pipeline Insight, 2021,” report provides comprehensive insights about 2+ companies and 2+ pipeline...
March 2021
60 pages
Cerebral Infarction - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Cerebral Infarction – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipelin...
March 2021
120 pages
Mydriasis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Mydriasis – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in M...
March 2021
60 pages
Tuberous Sclerosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Tuberous Sclerosis – Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pipeline d...
March 2021
60 pages
Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2021
US$ 1,500.00
... chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chemotherapy Induced Nausea and Vomiting The report also ...
February 2021
80 pages
Gallbladder cancer - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Gallbladder Cancer - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gallbladder Cancer development. The report provides ...
February 2021
60 pages
Yellow Fever- Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Yellow Fever - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Yellow Fever development. The report provides ...
February 2021
60 pages
End-Stage Renal Disease - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for End-Stage Kidney Disease The report also covers ...
February 2021
60 pages
Non-Small-Cell Lung Carcinoma (NSCLC) - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Non-Small Cell Lung Cancer The report also ...
February 2021
60 pages
Graves Ophthalmopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Graves Ophthalmopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipe...
February 2021
60 pages
IgA Nephropathy- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “IgA Nephropathy – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline...
February 2021
60 pages
MALT Lymhoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mucosa-associated Lymphoid Tissue (MALT) Lymphoma – Pipeline Insight, 2021,” report provides comprehensive insights ab...
February 2021
60 pages
Mild To Moderate Plaque Psoriasis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mild To Moderate Plaque Psoriasis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies...
February 2021
60 pages
Postoperative pain - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “Postoperative pain - Pipeline Insight, 2021,” report provides comprehensive insights about 60+ companies and 60+...
February 2021
200 pages
ACALABRUTINIB - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ACALABRUTINIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product...
February 2021
30 pages
Aliqopa - Drug Insight and Market Forecast - 2030
US$ 2,750.00
This report can be delivered to the clients within 48 Hours OVERVIEW “Aliqopa - Drug Insight and Market Forecast - 2030” report by DelveInsight outlays comprehensive insights of the product indicate...
February 2021
30 pages
ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product fo...
February 2021
30 pages
ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product f...
February 2021
30 pages
BI 764524 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “BI 764524 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
BLINATUMOMAB - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “BLINATUMOMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product f...
February 2021
30 pages
DB-102 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “DB-102 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Dif...
February 2021
30 pages
E-Selectin inhibitor– Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hrs DelveInsight’s, “E-Selectin inhibitor– Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 7+ pipeline dr...
February 2021
60 pages
RG 7774 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “RG 7774 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Di...
February 2021
30 pages
TREAKISYM - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “TREAKISYM - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
VENGLUSTAT - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “VENGLUSTAT - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
Zydelig - Drug Insight and Market Forecast - 2030
US$ 2,750.00
This report can be delivered to the clients within 48 Hours OVERVIEW “Zydelig - Drug Insight and Market Forecast - 2030” report by DelveInsight outlays comprehensive insights of the product indicate...
February 2021
30 pages
Abnormal Glucose tolerance-Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Abnormal Glucose Tolerance – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+...
February 2021
60 pages
Advanced Urotheilal carcinoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Advanced Urothelial Carcinoma – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies an...
February 2021
60 pages
Alpha Thalassemia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Alpha Thalassemia – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline...
February 2021
60 pages
